USANA Health Sciences, Inc. announced its financial results for its fiscal fourth quarter and fiscal year, ending January 3, 2026. Net sales in fiscal 2025 reached $925 million, an 8% improvement year over year. Net earnings during the year were $10.8 million with a diluted EPS of $0.58 and an adjusted EBITDA of $101.3 million.
“USANA delivered fourth quarter net sales in line with our preliminary results announced on January 12, 2026,” said Kevin Guest, USANA Chairman and Chief Executive Officer. “We began to see signs of stabilization in active customer counts in our core nutritional business as net sales in this segment increased modestly sequentially, led by growth in key markets including mainland China, the United States and Canada. Meanwhile, our omnichannel brands, Hiya and Rise, posted solid year-over-year growth.”
The increase in net sales was primarily driven by a full-year contribution from its Hiya segment, as the company’s core nutritional business declined by 8%. The company continues to execute a diversification strategy towards an omnichannel model designed to support growth beyond its core nutritional business and to restructure and modernize for an evolving marketplace.
Fourth quarter 2025 core nutritional business showed strength in Southeast Asia Pacific, with net sales showing a 17% sequential growth. Americas and Europe were also stable, with 4% sequential improvement in net sales. Fourth quarter Hiya direct to consumer sales resulted in $30 million in net sales and more than 181,000 active monthly subscribers.
“Rise Wellness generated strong momentum with sales tripling, albeit off a small base in 2024, as distribution expanded into key retail outlets,” Guest said. “The business is on pace for a robust year of sales growth supported by the launch of Protein Pop at a large club retailer in the first quarter. Net sales outside of our core nutritional business represented 16% of consolidated net sales in 2025, up from approximately 1% in 2024. We expect this share to increase to more than 20% of consolidated net sales in fiscal 2026.”
The company ended the year with $158 million in cash and cash equivalents with $14 million of debt. Fiscal year 2026 outlook now includes consolidated net sales between $925 million to $1 billion with an adjusted EBITDA of $101.3 million to $109.3 million.
